UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000053458
Receipt number R000060995
Scientific Title Relationship between early extubation and postoperative outcomes after esophagectomy in patients with thoracic esophageal cancer
Date of disclosure of the study information 2024/02/01
Last modified on 2024/01/27 09:50:35

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Relationship between early extubation and postoperative outcomes after esophagectomy in patients with thoracic esophageal cancer

Acronym

Impact of early extubation after esophagectomy

Scientific Title

Relationship between early extubation and postoperative outcomes after esophagectomy in patients with thoracic esophageal cancer

Scientific Title:Acronym

Impact of early extubation after esophagectomy

Region

Japan


Condition

Condition

Esophageal cancer

Classification by specialty

Gastrointestinal surgery Anesthesiology Intensive care medicine

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Esophagectomy for esophageal cancer is highly invasive among surgical procedures, and the morbidity and mortality remains high. Overnight mechanical ventilation and extubation on postoperative day 1 was historically selected to avoid postoperative adverse events. However, early extubation was introduced to prevent the pulmonary complication and promot early ambulation and early recovery.
This study aims to determine the impact of early extubation strategies after esophageal cancer surgery on major outcomes including the postoperative complications.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Major postoperative complications based on Clavien-Dindo classification
Including respiratory complications (pneumonia, atelectasis/impaired sputum drainage, tracheal fistula/bronchial fistula, pulmonary fistula, pleural effusion, chylothorax), infectious complications (wound infection, suture failure, sepsis) and thrombotic complications ( myocardial infarction, stroke, pulmonary embolism, deep vein thrombosis)

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. Patients who underwent radical esophagectomy with thoracoscopic assistance for esophageal cancer between September 1, 2018, and August 31, 2023 and were admitted to the intensive care unit.
2. Patients aged 18 years or older at surgery

Key exclusion criteria

Cases in which the surgical procedure had changed to open heart surgery

Target sample size

450


Research contact person

Name of lead principal investigator

1st name Shuji
Middle name
Last name Okahara

Organization

Okayama Univarsity Hospital

Division name

Department of Intensive Care

Zip code

7008558

Address

2-5-1 Shikatacho, Kitaku, Okayama city

TEL

086-235-7778

Email

shuji.okahara@okayama-u.ac.jp


Public contact

Name of contact person

1st name Shuji
Middle name
Last name Okahara

Organization

Okayama Univarsity Hospital

Division name

Department of Intensive Care

Zip code

7008558

Address

2-5-1 Shikatacho, Kitaku, Okayama city

TEL

086-235-7778

Homepage URL


Email

shuji.okahara@okayama-u.ac.jp


Sponsor or person

Institute

Okayama Univarsity

Institute

Department

Personal name



Funding Source

Organization

Self funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Okayama Univarsity

Address

2-5-1 Shikatacho, Kitaku, Okayama city

Tel

086-235-6938

Email

mae6605@adm.okayama-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 02 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2024 Year 01 Month 19 Day

Date of IRB

2024 Year 01 Month 19 Day

Anticipated trial start date

2024 Year 02 Month 01 Day

Last follow-up date

2025 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

This study is a retrospective observational study with an observation period from September 2018 to August 2023.
Cases who underwent surgery for esophageal cancer before early extubation strategy (September 2018 to March 2021) (conventional group) and those who underwent surgery after the strategy (April 2021 to August 2023) are retrospectively collected.
We extract cases extubated on the surgery day after esophagectomy from April 2021 to August 2023 (early extubation group). To control for potential differences in patient characteristics between groups, propensity score matching is used to compare clinical outcomes.


Management information

Registered date

2024 Year 01 Month 27 Day

Last modified on

2024 Year 01 Month 27 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000060995


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name